Literature DB >> 11006243

Role and expression of CD40 on human retinal pigment epithelial cells.

F Willermain1, L Caspers-Velu, N Baudson, C Dubois, M Hamdane, F Willems, T Velu, C Bruyns.   

Abstract

PURPOSE: To examine the CD40 costimulatory molecule expression on normal resting or activated adult human retinal pigment epithelium (hRPE) cells and to evaluate its role as an activation molecule considering the potential antigen presentation functions of hRPE cells.
METHODS: Expression of HLA-DR and costimulatory (CD40, B7.1, B7.2, CD54, and CD58) molecules on hRPE cells was analyzed by flow cytometry. CD40 triggering was performed using soluble CD40L or cocultures with CD40L transfected fibroblasts. Interleukin (IL)-6, -8, -10, and -12 secretions were measured by enzyme-linked immunosorbent assay. Antigen presentation function of hRPE cells was assessed by coculturing hRPE cells with allogeneic T cells. T-cell proliferation was measured by [(3)H]-thymidine incorporation, and T-cell apoptosis by measurement of caspase-3 activity.
RESULTS: Interferon (IFN)gamma-activated hRPE cells expressed CD40, but not B7.1 or B7.2. Although interferongamma enhanced IL-6 and IL-8 production, CD40 triggering of IFNgamma-activated hRPE cells did not induce IL-12 secretion. hRPE cells did not stimulate allogeneic resting T cells and downregulated phytohemagglutinin-activated allogeneic T cells via a cell-to-cell contact-dependent mechanism. Some induction of apoptosis was detected.
CONCLUSIONS: CD40 is expressed on IFNgamma-activated hRPE cells. Its ligation leads to an increased production of IL-6 and IL-8 but fails to induce B7.1 or B7. 2 expression, or to induce IL-12 secretion. Accordingly, hRPE cells do not activate allogenic T cells but inhibit T-cell proliferation, partly through induction of apoptosis. These results suggest that hRPE cells could be implicated more in a deviant antigen presentation. If the exact molecular mechanisms are unclear, it is likely that CD40-CD40L interaction could play a role in this process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006243

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells.

Authors:  Wen-Chuan Wu; Dan-Ning Hu; Hua-Xin Gao; Min Chen; Dawei Wang; Richard Rosen; Steven A McCormick
Journal:  Mol Vis       Date:  2010-09-12       Impact factor: 2.367

2.  Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eye.

Authors:  F Willermain; L Caspers-Velu; B Nowak; P Stordeur; R Mosselmans; I Salmon; T Velu; C Bruyns
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

3.  CD40 induces anti-Toxoplasma gondii activity in nonhematopoietic cells dependent on autophagy proteins.

Authors:  Jennifer Van Grol; Luis Muniz-Feliciano; Jose-Andres C Portillo; Vera L Bonilha; Carlos S Subauste
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

4.  Distinct CD40L receptors mediate inflammasome activation and secretion of IL-1β and MCP-1 in cultured human retinal pigment epithelial cells.

Authors:  Zong-Mei Bian; Matthew G Field; Susan G Elner; J Michelle Kahlenberg; Victor M Elner
Journal:  Exp Eye Res       Date:  2018-02-16       Impact factor: 3.467

5.  P2Y2R deficiency attenuates experimental autoimmune uveitis development.

Authors:  Lia Judice M Relvas; Maya Makhoul; Remi Dewispelaere; Laure Caspers; Didier Communi; Jean-Marie Boeynaems; Bernard Robaye; Catherine Bruyns; François Willermain
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

6.  Immunological Properties of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells.

Authors:  Masha Idelson; Ruslana Alper; Alexey Obolensky; Nurit Yachimovich-Cohen; Jacob Rachmilewitz; Ayala Ejzenberg; Ekaterina Beider; Eyal Banin; Benjamin Reubinoff
Journal:  Stem Cell Reports       Date:  2018-08-16       Impact factor: 7.765

7.  Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations.

Authors:  Yousof Taghavi; Gholamhossein Hassanshahi; Nicholas G Kounis; Ioanna Koniari; Hossein Khorramdelazad
Journal:  J Cell Commun Signal       Date:  2019-01-03       Impact factor: 5.908

Review 8.  The relationship between intervention in the CD40 signal pathway and choroidal neovascularization.

Authors:  Peipei Zhang; Yan Su; Fang Liu
Journal:  Onco Targets Ther       Date:  2014-02-14       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.